A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche · NCT06318169
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 3
- Target enrollment
- 1350
- US sites recruiting
- 136
- Study start
- March 13, 2024
- Record last updated
- October 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.
Being studied: Pegozafermin; Placebo
Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Key Inclusion Criteria
- Males or non-pregnant females aged between 18 and 80 years (inclusive) at time of signing the informed consent form (ICF)
- Biopsy-confirmed MASH with fibrosis stage F2 or F3
- Body mass index (BMI) at screening ≥25.0 kilograms (kg)/meters squared (m\^2) (≥23 kg/m\^2 for Asian participants).
Key Exclusion Criteria
- Chronic liver diseases other than MASH
- Evidence of cirrhosis on screening liver biopsy
- Have type 1 diabetes or poorly controlled type 2 diabetes
- Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) ≥250 units per liter (U/L)
- Participants taking vitamin E (>400 international units [IU]/day) or pioglitazone must be on stable dose for at least 6 months prior to Screening
Other inclusion and exclusion criteria may apply.
Recruiting US locations
89bio Clinical Study Site
Birmingham, AL 35209
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Chandler, AZ 85224
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Glendale, AZ 85036
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Sun City, AZ 85351
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Tucson, AZ 85712-4018
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Tucson, AZ 85716
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Little Rock, AR 72211-3859
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
North Little Rock, AR 72117
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Canoga Park, CA 91604
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Coronado, CA 92118
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Escondido, CA 92025
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Fountain Valley, CA 92708
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Fresno, CA 93720
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Gardena, CA 90247
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
La Jolla, CA 92037
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Lancaster, CA 93534
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Long Beach, CA 90815
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Montclair, CA 91763
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Orange, CA 92868
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Pasadena, CA 91105
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Poway, CA 92064
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Rialto, CA 92377
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Stanford, CA 94305
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Victorville, CA 92395
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Littleton, CO 80120
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Brandon, FL 33511
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Clermont, FL 34711
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Fort Myers, FL 33912
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Hialeah Gardens, FL 33016
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Homestead, FL 33030
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Jacksonville, FL 32256
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Jupiter, FL 33458
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Lady Lake, FL 32159-6831
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Lakewood Rch, FL 34211
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Lehigh Acres, FL 33936
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Maitland, FL 32751-7258
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Miami, FL 33176
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
New Port Richey, FL 34653
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Ocala, FL 34471
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Ocoee, FL 34761
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Sarasota, FL 34240
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Winter Park, FL 32789
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Athens, GA 30607
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Dalton, GA 30720
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Marietta, GA 30060
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Chicago, IL 60611
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Hammond, IN 46324
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
New Albany, IN 47150
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
South Bend, IN 46635
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Iowa City, IA 52242
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Topeka, KS 66606
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Louisville, KY 40218
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Covington, LA 70433
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Houma, LA 70360
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Lake Charles, LA 70605
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Marrero, LA 70072
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
West Monroe, LA 71291
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Baltimore, MD 21202
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Glen Burnie, MD 21061
Site contact: 89bio Clinical Study Site
89bio Clinical Study Site
Greenbelt, MD 20770
Site contact: 89bio Clinical Study Site
+ 76 more on the official record.
Study contacts (from the official record)
- Reference Study ID Number: BIO89-100-131 ENLIGHTEN clinical trial / No attachments to email below. · 888-662-6728 (U.S. Only) · global-roche-genentech-trials@gene.com
- Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Similar studies in Alabama
All nutrition & metabolism studies in Alabama →- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Birmingham, AL + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- Birmingham, AL + 131 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Pfizer
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Akero Therapeutics, Inc
- Location
- Birmingham, AL + 130 other US sites
- Eligibility basics
- Ages 18–80